506 related articles for article (PubMed ID: 11194733)
1. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease.
Xia HH; Phung N; Kalantar JS; Talley NJ
Med J Aust; 2000 Nov; 173(10):515-9. PubMed ID: 11194733
[TBL] [Abstract][Full Text] [Related]
2. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India.
Goenka MK; Majumder S; Sethy PK; Chakraborty M
Indian J Gastroenterol; 2011 Feb; 30(1):33-7. PubMed ID: 21424697
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.
Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W
Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527
[TBL] [Abstract][Full Text] [Related]
7. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
8. Frequency of NSAID induced peptic ulcer disease.
Hamid S; Yakoob J; Jafri W; Islam S; Abid S; Islam M
J Pak Med Assoc; 2006 May; 56(5):218-22. PubMed ID: 16767948
[TBL] [Abstract][Full Text] [Related]
9. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
10. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M
Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233
[TBL] [Abstract][Full Text] [Related]
11. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
[TBL] [Abstract][Full Text] [Related]
13. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
[TBL] [Abstract][Full Text] [Related]
14. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study.
Xia HH; Wong BC; Wong KW; Wong SY; Wong WM; Lai KC; Hu WH; Chan CK; Lam SK
Aliment Pharmacol Ther; 2001 Dec; 15(12):1875-82. PubMed ID: 11736717
[TBL] [Abstract][Full Text] [Related]
15. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population.
Nishikawa K; Sugiyama T; Kato M; Ishizuka J; Komatsu Y; Kagaya H; Katagiri M; Nishikawa S; Hokari K; Takeda H; Asaka M
Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):635-40. PubMed ID: 10912481
[TBL] [Abstract][Full Text] [Related]
16. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
17. Etiology and treatment of childhood peptic ulcer disease in Taiwan: a single center 9-year experience.
Huang SC; Sheu BS; Lee SC; Yang HB; Yang YJ
J Formos Med Assoc; 2010 Jan; 109(1):75-81. PubMed ID: 20123589
[TBL] [Abstract][Full Text] [Related]
18. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics.
Arkkila PE; Kokkola A; Seppälä K; Sipponen P
Scand J Gastroenterol; 2007 Jun; 42(6):695-701. PubMed ID: 17505991
[TBL] [Abstract][Full Text] [Related]
19. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
20. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period.
Arents NL; Thijs JC; van Zwet AA; Kleibeuker JH
Eur J Gastroenterol Hepatol; 2004 Aug; 16(8):779-83. PubMed ID: 15256980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
